31 Jan 2026Open access
Nanodrugs therapy for combating antimicrobial resistance: a review on green silver nanoparticlesPublisher siteInvestigational Medicinal Chemistry and Pharmacology, Nanoparticles: synthesis and applications
Active, last published 2026
In mesoporous materials and catalysis
David Oluwaseyi
Israel
Scholar“Research focused on Mesoporous Materials and Catalysis and adjacent fields.”
Claim Your Profile1
H-index
3
Citations
David has not officially claimed their profile. If you are David, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
avid Oluwaseyi Israel is a researcher working on Mesoporous Materials and Catalysis. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
David's work has been cited 3 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Mesoporous Materials and Catalysis×2
04 · Where I am
Affiliations
Affiliation on published researchFederal University of Agriculture, NigeriaDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works3 Apr 2024Open access2cites
Green Synthesis, Hybridization of SiO<sub>2</sub> by Alkaline -Acid Leaching Method and their Optical and Structural Properties Using Rice Husk and <i>Anogeissus leiocarpus</i> ExtractPublisher siteNano hybrids and composites, Mesoporous Materials and Catalysis
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you David?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you